Learn The Latest Innovations in Regenerative Medicine in Less than 15 Minutes
Peer-reviewed education written for practitioners. Updated regularly.
Investigational Research
PRF vs PRP: Preparation, Growth-Factor Release, Clinical Evidence and Where Exosomes Fit
PRF vs PRP compared on spin, anticoagulant and growth-factor release, the facial, hair and rotator cuff trials, US regulatory status, and where exosomes fit.
Aesthetic Science
Exosomes or PRP for Facial Treatments: Method, Patient Selection, and the Depth That Governs Both
The one investigator-blinded split-face trial comparing the two materials on photoaged facial skin, how each is prepared, and the depth that governs both.
Hair Restoration Research
Scalp Microneedling and Topical Anesthesia: The Procedure Side of a Hair Protocol
What the 2024 and 2025 microneedling meta-analyses report, what four PRP meta-analyses since 2024 add and where spin protocol enters, what the exosome-after-needling scoping review and open-label study contain, what the topical anesthetic literature and one paper on platelets say, and why a cleared microneedling device is cleared to needle rather than to deliver. 16 sources, thirteen from 2011 onward.
Thyroid, Estrogens and Androgens: The Hormonal Context of Shedding in an Optimization Practice
What the thyroid literature reports about diffuse shedding, what the menopause and estrogen literature contains and why a 2026 systematic review had to untangle it, what the androgen literature reports in people receiving testosterone and in hyperandrogenic states, where the guidelines place the antiandrogen question in women, and what ExaVeyra does and does not supply. 16 sources, twelve from 2011 onward.
Biotin, Vitamin D and B12: Where Deficiency Matters, Where It Does Not, and the Lab Notice Practices Miss
What four meta-analyses report on vitamin D deficiency across the alopecias, why the biotin reviews support supplementation only in documented deficiency, what the FDA warned about biotin and laboratory assays, what the iron and trace-element literature contains, and what a compounded injectable cofactor is. 14 sources, twelve from 2011 onward.
Thymosin Beta-4, TB-500, and Follicle Stem Cells: An Animal-Data Review
Why the hair literature belongs to thymosin beta-4, a 43-residue protein studied in rodents, goats and follicle cells, and not to TB-500, the seven-residue fragment sold on that research; what the 2004 to 2021 animal work reports; why none of it transfers to a blend; and where the FDA lists the fragment. 14 sources, ten from 2011 onward.
Ketoconazole and Azelaic Acid as Scalp Adjuncts: Two Side Doors into the Hair Literature
What the 1998 shampoo study, two systematic reviews and the 2026 scalp-microbiome literature report for topical ketoconazole, what a single 1988 in vitro enzyme study means for azelaic acid, where the guidelines and network analyses place each, and what a compounded ketoconazole and niacinamide cream is under section 503A. 17 sources, twelve from 2011 onward.
Hair and Scalp Protocol Components 2026: What the Literature Supports for Each Formulation Class
A tiered map of finasteride, minoxidil combinations, ketoconazole and azelaic acid, GHK-Cu, thymosin beta-4, exosomes, nutritional and hormonal context and scalp procedures: what the peer-reviewed literature reports, what the FDA says about each, and what a licensed practice can source under which regime. 36 primary sources.
Exosomes for Hair Restoration: What the Research Says
A clinician-facing review of MSC-derived exosome research in hair restoration: follicle biology, Wnt/beta-catenin signaling, the 2025 systematic reviews and registered trials, comparisons with PRP, available formats and documentation, and supplier due diligence. Expanded September 2026 with 18 sources.
Regenerative Science
Wharton's Jelly as an MSC Source: Why Tissue Origin Determines Secretome and Vesicle Cargo
A chemist-authored review of Wharton's jelly as a mesenchymal stromal cell source: perivascular anatomy, donor-age advantage, HLA-DR negative immunophenotype, comparative secretome proteomics, extracellular vesicle biophysics, and the sourcing questions that separate a characterized product from an unverified one. 24 annotated sources.
Exosomes vs PRP: A Research Comparison for Practitioners
A side-by-side review of MSC-derived exosomes and platelet-rich plasma mechanism differences, evidence base, regulatory frameworks, and practical sourcing considerations for licensed clinicians.
What Are Exosomes? A Clinician's Guide to MSC-Derived Biologics
A structured primer on exosome biology for licensed practitioners: biogenesis, cargo composition, MSC source differences, manufacturing standards, and regulatory framing for clinical use.
Hormone Optimization
Peptides Alongside Testosterone, Estradiol, and Progesterone: A Mechanism-Based Review
A mechanism-based literature review for licensed prescribers on how peptides interact with testosterone, estradiol, and progesterone protocols. Covers the GH/IGF-1 axis, HPG feedback, central desire circuitry, and documented pharmacokinetic interactions. 27 cited sources.
503A Compounded Hormone Optimization: A Chemist's Guide to Supply Chain Integrity for HRT Clinics
A chemist-authored guide to 503A compounded HRT supply chain integrity covering testosterone, estradiol, progesterone, and growth hormone secretagogues. Peer-reviewed citations included.
Longevity Medicine
Peptides and Exosomes in Concierge Longevity Medicine: How Combination Protocols Work
A practitioner-focused look at how concierge and longevity clinics approach peptide and exosome protocols: the science, the 503A/503B sourcing pathways, the regulatory status of exosomes, and the compliance guardrails every program needs.
Pharmacy Regulations
2026 FDA 503A Peptide Category Changes: What Concierge and Longevity Clinics Need to Know
The FDA’s evolving review of bulk drug substances is reshaping which peptides 503A pharmacies can compound. A practitioner-focused guide to the category framework, what changed heading into 2026, and how to keep a peptide program compliant.
GLP-1 and Compounded Peptides After the 2026 503A Shakeup: What Clinics Should Know
When the GLP-1 shortage ended, the compounding rules changed with it. How shortage status, the 503A/503B distinction, and the 2026 peptide category review together determine what a clinic can and cannot compound.
Regulatory & Compliance
Are Exosome Products FDA-Approved? The 2026 Legal and Compliance Landscape
A clear, current answer to the question clinics and patients ask most: are exosome products FDA-approved? Covers the regulatory status, the intended-use statement, and how to describe exosomes without crossing a claims line.
Practice Growth
Adding a Regenerative Medicine Service Line to a Concierge Practice: A Compliance-First Playbook
A practical, compliance-first guide for concierge and longevity practices evaluating a regenerative service line: how to scope offerings, source responsibly, structure consent and marketing, and build a program that holds up to scrutiny.
Practitioner Guides
The CuraCator™ Clinical Method: Advancing PRP and Biologic Delivery in Medspa and Dermatology Practices
A chemist-authored clinical review of PRP application science, microchannel delivery biophysics, and the CuraCator Clinical Method for medspa and dermatology practices. Covers platelet activation, growth factor release kinetics, delivery depth, and the evidence base for combining PRP with microchannel protocols.
Precision Medicine Research
When Genomics Meets Regeneration: How AI-Driven Precision Medicine Is Redefining Cell Therapy
A peer-reviewed overview of how AI, multi-omics profiling, and genomic data are converging to enable personalized cell therapy and precision regenerative medicine protocols for licensed practitioners.
Dermatology Research
Stay current on regenerative medicine
Peer-reviewed education on exosomes, compounding pharmacy regulations, and aesthetic science delivered to practitioners who need to stay ahead.
No spam. Unsubscribe any time.
Go Deeper
Beyond the blog: practitioner sourcing guides and detailed regulatory references.
Sourcing Guide
Exosome Sourcing for Clinics
COA requirements, analytical characterization standards, supplier red flags, and quality benchmarks.
Read →Regulatory Guide
503A & 503B Compounding
Full compliance guide for clinic sourcing of compounded medications.
Read →Science
Explore the Science
Interactive 3D exosome explorer, publications database, and mechanism of action.
Read →